Effective 1 de enero de 2021, the policy for Retinal Telescreening for Diabetic Retinopathy has been updated to reflect that primary care providers are now allowed to bill for this service. This change is effective for BlueCHiP for Medicare and commercial products. Please see the full text of this policy here.